TD Cowen raised the firm’s price target on NOV Inc. to $28 from $27 and keeps a Buy rating on the shares. The firm noted they reported EBITDA 3% ahead of consensus along with solid orders and FCF. However guidance implies 2H slightly below expectations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV: